TESTING
TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE
By Imogen
Evans, Hazel Thornton, and Iain Chalmers
REFERENCES 116 - 139
116 Hanley B, Truesdale A, King A, et al. Involving consumers in
designing, conducting,
and interpreting randomised controlled trials: questionnaire survey.
British Medical
Journal 2001;322:519–23.
117 Oliver S, Clarke-Jones L, Rees R, et al. Involving consumers in
research and development agenda setting for the NHS: developing an
evidence-based approach. Health Technology Assessment 2004;8:no.15.
118 Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke:
consumer involvement in design of new randomised controlled trial.
British Medical Journal 2002;325:415–7.
119 Thornton H, Edwards A, Elwyn G. Evolving the multiple roles of
‘patients’ in healthcare
research: reflections after involvement in a trial of shared
decision-making.
Health Expectations 2003;6:189–97.
120 Chalmers I. Minimising harm and maximising benefit during
innovation in healthcare: controlled or uncontrolled experimentation?
Birth 1986;13;155–64.
121 Kushner R. Breast cancer: a personal history and an investigative
report. New York:
Harcourt Brace Jovanovitch, 1975.
122 Lerner BH. The breast cancer wars: hope, fear, and the pursuit of a
cure in twentieth-century America. New York: Oxford University Press,
2003.
123 Faulder C. Always a woman: a practical guide to living with breast
surgery. (Published in association with the Breast Care and
Mastectomy Association). London: Thorsons, 1992, pp28–9;73;164–6.
124 Breast Cancer Care. Some of the most memorable events and
milestones in our
history. Available from: http://80.175.42.169/content.php?page_id=1338
[accessed
8 December 2005].
125 Institute of Medical Ethics Working Party on the ethical
implications of AIDS: AIDS,
ethics, and clinical trials. British Medical Journal 1992;305:699–701.
126 Thornton H. The patient’s role in research. [Paper given at The
Lancet ‘Challenge of
Breast Cancer’ Conference, Brugge, April 1994.] In: Health Committee
Third Report. Breast cancer services. Volume II. Minutes of evidence
and appendices. London: HMSO, July 1995, 112–4.
127 Concorde Coordinating Committee. Concorde: MRC/ANRS randomised
doubleblind controlled trial of immediate and deferred zidovudine in
symptom-free HIV infection. Lancet 1994;343:871–81.
128 Royal Courts of Justice. In the High Court of Justice, Family
Division. Neutral citation [2002] EWHC 2734 (Fam). Cases nos:
FD02p01866 & FD02p01867. 11 December 2002.
129 Herceptin and early breast cancer: a moment for caution
[Editorial]. Lancet 2005;366:1673.
130 Hanley B, Truesdale A, King A, et al. Involving consumers in
designing, conducting
and interpreting randomised controlled trials: questionnaire survey.
British Medical Journal 2001, 322:519–23.
131 Rice GPA, Incorvaia B, Munari L, et al. Interferon in
relapsing-remitting multiple
sclerosis. The Cochrane Database of Systematic Reviews 2001, Issue 4.
Art. No.: CD002002.
Available from: www.thecochranelibrary.com [accessed 3 January 2006].
132 Herxheimer A. Relationships between the pharmaceutical industry and
patients’
organisations. British Medical Journal 2003;326:1208–10.
133 Consumers’ Association. Who’s injecting the cash? Which? 2003,
April, pp24–5.
134 Thornton H, Edwards A, Elwyn G. Evolving the multiple roles of
‘patients’ in healthcare
research: reflections after involvement in a trial of shared
decision-making. Health Expectations 2003;6;189–97.
135 Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke:
consumer involvement in design of new randomised controlled trial.
British Medical Journal 2002;325:415–7.
136 Hamdy FC. The ProtecT Study (Prostate testing for cancer and
Treatment), 2001. Available from:
www.shef.ac.uk/dcss/medical/urology/research/topic2.html
[accessed 8 December 2005].
137 Oliver S, Clarke-Jones L, Rees R, et al. Involving consumers in
research and development agenda setting for the NHS: developing an
evidence-based approach. Health Technology Assessment 2004;8:no.15.
138 Minot GR, Murphy WP. Treatment of pernicious anemia by a special
diet. Journal of
the American Medical Association 1926;87:470–6.
139 House of Commons Health Committee. The influence of the
pharmaceutical industry. Fourth Report of Session 2004–05. London:
Stationery Office, 2005. Available from:
www.publications.parliament.uk/pa/cm200405/cmselect/ cmhealth/42/42.pdf
[accessed 1 January 2006].
|
